The Latest in Dermatology

Internal Medicine News

Biosimilars and patients: Discussions should address safety, cost, and anxiety about change

March 30, 2023

Internal Medicine News

Limited treatment options exist for brittle nail syndrome

March 29, 2023

Dermatology

Internal Medicine News

JAK inhibitor ivarmacitinib shows efficacy for atopic dermatitis in a pivotal trial

March 29, 2023

Internal Medicine News

Topical delgocitinib shows promise for chronic hand eczema, pivotal trial shows

March 27, 2023

Dermatology

Internal Medicine News

Air pollution may be causing eczema

March 27, 2023

Dermatology

Internal Medicine News

FDA approves new formulation of Hyrimoz adalimumab biosimilar

March 27, 2023

Internal Medicine News

Anifrolumab shows promise in refractory discoid lupus erythematosus

March 27, 2023

Internal Medicine News

New data forecast more oral PDE4 inhibitors for psoriasis

March 27, 2023

Dermatology

Internal Medicine News

New JAK inhibitor study data confirm benefit in alopecia areata

March 24, 2023

Dermatology

Internal Medicine News

Pilot study evaluates sensitive skin burden in persons of color

March 23, 2023

Internal Medicine News

Expert shares her tips for diagnosing, treating onychomycosis

March 23, 2023

Internal Medicine News

Cases of potentially deadly fungus jump 200%: CDC

March 22, 2023

Internal Medicine News

Phase 3 prurigo nodularis trial shows positive results for nemolizumab

March 22, 2023

Internal Medicine News

Novel therapy shows promise for treating skin-predominant dermatomyositis

March 21, 2023

Internal Medicine News

Studies validate IL-17 as hidradenitis suppurativa drug target

March 20, 2023

Dermatology